obesity

Novo adds weight to its obesity goals
EP Vantage
Thu, 09/10/20 - 10:17 am
Novo Nordisk
semaglutide
obesity
Highlights: 2020 Cardiometabolic Health Congress West Live Online
CP WIre
Fri, 08/21/20 - 12:10 pm
cardiometabolic health
cardiovascular disease
obesity
Novo Nordisk axes experimental obesity drugs after success with later-stage meds
Fierce Biotech
Thu, 08/6/20 - 11:20 pm
Novo Nordisk
obesity
semaglutide
Heart Drugs May Influence Gut Microbiome In Obese People, Says New Study
Forbes
Thu, 05/7/20 - 12:06 am
microbiome
obesity
statins
Will Novo’s big thinking in obesity pay off?
EP Vantage
Thu, 04/16/20 - 10:32 am
Novo Nordisk
obesity
Ozempic
AM833
clinical trials
Insights into how Novo Nordisk's Saxenda cuts food cravings may inspire new obesity drugs
Fierce Biotech
Thu, 03/5/20 - 11:05 pm
Novo Nordisk
Saxenda
obesity
food cravings
Kintai’s obesity drug that works via the gut microbiome moves closer to the clinic
Fierce Biotech
Wed, 01/22/20 - 06:39 pm
microbiome
obesity
Kintai Therapeutics
Gene therapy to fend off aging? Buzzy Harvard startup Rejuvenate Bio says it works in mice
Fierce Biotech
Tue, 11/5/19 - 10:22 am
gene therapy
age-related disease
type 2 diabetes
obesity
heart failure
kidney failure
Rejuvenate Bio
Highlights: 2019 Cardiometabolic Health Congress, Chicago IL
CP Wire
Tue, 10/29/19 - 01:55 pm
cardiometabolic health
GLP-1 agonist
diabetes
lipids
hypertension
chronic kidney disease
heart failure
obesity
Highlights: 2019 Cardiometabolic Health Congress, Chicago IL
Tue, 10/29/19 - 01:54 pm
cardiometabolic health
GLP-1 agonist
diabetes
lipids
hypertension
chronic kidney disease
heart failure
obesity
Novo Nordisk announces obesity digital health tie-up with Noom
Pharmaforum
Thu, 10/3/19 - 10:53 am
Novo Nordisk
Noom
digital health
obesity
J&J dumps Hanmi obesity drug following midphase trials
Fierce Biotech
Mon, 07/8/19 - 10:51 am
JNJ
HM12525A
obesity
Hanmi Pharmaceutical
Boehringer Ingelheim, Gubra to develop anti-obesity peptide poly-agonists
Pharmaceutical Business Review
Thu, 05/30/19 - 10:05 am
obesity
peptide poly-agonists
Boehringer Ingelheim
Gubra
Even as obesity rates climb, new diabetes cases fall
Stat
Tue, 05/28/19 - 11:54 am
diabetes
obesity
FDA approves PureTech’s obesity device Plenity
Pharmaforum
Mon, 04/15/19 - 10:27 am
FDA
PureTech Health
devices
obesity
Plenity
Obalon to lay off half its workforce in retail pivot
Mass Device
Wed, 04/3/19 - 12:16 pm
Obalon
layoffs
devices
obesity
Merck doubles down on NGM Bio pact but culls obesity drug
Fierce Biotech
Wed, 03/20/19 - 12:15 pm
Merck
R&D
NGM Biopharmaceuticals
NP201
NASH
obesity
With Obesity on the Continued Rise in the U.S., More Anti-Obesity Drugs Are Heading for the Market
BioSpace
Wed, 02/13/19 - 10:06 am
obesity
Sanofi
Novo Nordisk
AstraZeneca
Obalon Scores Funding on the Heels of Obesity Market Shift
Medical Devices and Diagnostics Industry
Fri, 12/28/18 - 01:05 pm
Obalon
obesity
devices
LNC Therapeutics Acquires Exclusive License for Microbes Potentially Related to Obesity
CP Wire
Thu, 10/18/18 - 12:35 am
LNC Therapeutics
microbiome
obesity

Pages